Approvals (Drugs@FDA)

TAFAMIDIS MEGLUMINE

AUROBINDO PHARMA LTD · TAFAMIDIS MEGLUMINE

ANDA218617Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218617
Sponsor name
AUROBINDO PHARMA LTD
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20261106
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    TAFAMIDIS MEGLUMINE
    Reference standard
    Yes
    Dosage form
    CAPSULE
    Route
    ORAL
    Marketing status
    Prescription
    Active ingredients
    1. Name
      TAFAMIDIS MEGLUMINE
      Strength
      20MG
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.